LYVISPAH

Drug Amneal Pharmaceuticals LLC
Total Payments
$68,941
Transactions
3,103
Doctors
1,563
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $14.60 1 1
2023 $48,418 2,843 1,410
2022 $20,508 259 211

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $52,891 3,096 76.7%
Consulting Fee $16,050 7 23.3%

Top Doctors Receiving Payments for LYVISPAH — Page 63

Doctor Specialty Location Total Records
, MD Pain Medicine Hurst, TX $12.35 1
, MD Neurological Surgery North Haven, CT $12.29 1
, M.D Clinical Neurophysiology Lapeer, MI $12.27 1
, NP-C Family Tucson, AZ $12.20 1
, PA-C Physician Assistant Amherst, NY $12.09 1
, MD Pain Medicine Mobile, AL $12.08 1
, M.D Sleep Medicine Voorhees, NJ $11.93 1
, MD Physical Medicine & Rehabilitation Cherry Hill, NJ $11.93 1
Taylor Jones Physician Assistant Voorhees, NJ $11.93 1
, M.D Neurology Granbury, TX $11.55 1
, M.D Neurology Mc Lean, VA $10.90 1
, M.D Clinical Neurophysiology Granbury, TX $7.98 1
, M.D Neurology Tampa, FL $4.96 1
, MD Neurology Oklahoma City, OK $4.83 1

About LYVISPAH

LYVISPAH is a drug associated with $68,941 in payments to 1,563 healthcare providers, recorded across 3,103 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.

Payment data is available from 2022 to 2024. In 2024, $14.60 was paid across 1 transactions to 1 doctors.

The most common payment nature for LYVISPAH is "Food and Beverage" ($52,891, 76.7% of total).